| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.18 | 1e-06 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.16 | 3e-06 |
| mRNA | SB590885 | GDSC1000 | pan-cancer | AAC | 0.12 | 9e-05 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.14 | 9e-05 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0001 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.18 | 0.0001 |
| mRNA | Axitinib | FIMM | pan-cancer | AAC | 0.58 | 0.0001 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0001 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0002 |
| mRNA | Pazopanib | FIMM | pan-cancer | AAC | 0.65 | 0.0002 |